Peanut allergy: Clinical and immunologic differences among patients from 3 different geographic regions
Top Cited Papers
- 31 March 2011
- journal article
- research article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 127 (3), 603-607
- https://doi.org/10.1016/j.jaci.2010.09.010
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Reported symptoms to peanut between 4 and 8 years among children sensitized to peanut and birch pollen – results from the BAMSE birth cohortAllergy, 2010
- The non‐specific lipid transfer protein, Ara h 9, is an important allergen in peanutClinical & Experimental Allergy, 2009
- EpidemAAITO: Features of food allergy in Italian adults attending allergy clinics: a multi‐centre studyClinical & Experimental Allergy, 2009
- Lipid transfer protein–linked hazelnut allergy in children from a non-Mediterranean birch-endemic areaJournal of Allergy and Clinical Immunology, 2008
- Original article: Two different profiles of peach allergy in the north of SpainAllergy, 2007
- Predictive value of skin prick tests using recombinant allergens for diagnosis of peanut allergyJournal of Allergy and Clinical Immunology, 2006
- Lipid transfer protein and vicilin are important walnut allergens in patients not allergic to pollenJournal of Allergy and Clinical Immunology, 2004
- Relevance of Ara h1, Ara h2 and Ara h3 in peanut‐allergic patients, as determined by immunoglobulin E Western blotting, basophil–histamine release and intracutaneous testing: Ara h2 is the most important peanut allergenClinical & Experimental Allergy, 2004
- Quantification of major peanut allergens Ara h 1 and Ara h 2 in the peanut varieties Runner, Spanish, Virginia, and Valencia, bred in different parts of the worldAllergy, 2001
- The Many Faces of the PeanutAllergy and Asthma Proceedings, 1989